We found that loss of Rb did not change the number of mice that do not develop HCC within one year, suggesting that Rb deletion does not affect cancer initiation and confirming that tumorigenesis is driven by activation of MYC in this mouse model (Figure 6A). This evidence concerns the gene RB1 and hepatocellular carcinoma.